Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancerEverett J. Moding, Maximilian Diehn, Rene F. Bonilla et al.|Nature Cancer|2020Cited by 369
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint InhibitionBarzin Y. Nabet, Maximilian Diehn, Mohammad Shahrokh Esfahani et al.|Cell|2020Cited by 360
<i>KEAP1/NFE2L2</i> Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase InhibitionMichael S. Binkley, Maximilian Diehn, Young-Jun Jeon et al.|Cancer Discovery|2020Cited by 172